Ulocuplumab (Anti-CXCR4 / CD184)

Synonyms: BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody

Ulocuplumab (Anti-CXCR4 / CD184) is a fully human IgG4 antibody, targeting CXCR4. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models. MW: 144.84 KD.

Ulocuplumab (Anti-CXCR4 / CD184)

Purity & Quality Control

≥99

Choose Selective CXCR Inhibitors

Biological Activity

Description Ulocuplumab (Anti-CXCR4 / CD184) is a fully human IgG4 antibody, targeting CXCR4. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models. MW: 144.84 KD.

Product Details

CAS No. 1375830-34-4
Molecular Weight 144.84 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ulocuplumab (Anti-CXCR4 / CD184) | Ulocuplumab (Anti-CXCR4 / CD184) supplier | purchase Ulocuplumab (Anti-CXCR4 / CD184) | Ulocuplumab (Anti-CXCR4 / CD184) cost | Ulocuplumab (Anti-CXCR4 / CD184) manufacturer | order Ulocuplumab (Anti-CXCR4 / CD184) | Ulocuplumab (Anti-CXCR4 / CD184) distributor